Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Block (ADRIB Trial)

Clinical trial NCT02630290 · COMPLETED

Trial details

NCT number: NCT02630290
Sponsor: Guangzhou First People's Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Radius Fractures Ulna Fractures Hand Injuries Wrist Injuries Forearm Injuries

Start date: 2015-12-01
Primary completion: 2016-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.